find the latest legal job
Monash University Director Workplace Relations
Category: Industrial Relations and Employment Law | Location: All Melbourne VIC
· Exceptional senior leadership role
View details
Personal Injury Lawyer - Melbourne Eastern Suburbs - 2-5 years PAE
Category: Personal Injury Law | Location: Lilydale VIC 3140
· Fulfilling role as part of a small team in a positive workplace
View details
Legal Counsel
Category: Banking and Finance Law | Location: Sydney CBD, Inner West & Eastern Suburbs Sydney NSW
· In-house opportunity · Be part of our engine for success in a high growth business
View details
Trainer/Assessor Diploma of Legal Services
Category: Other | Location: Liverpool NSW 2170
· 3 Days Per Week · 9am - 4pm
View details
Corporate and Commercial Partner
Category: Corporate and Commercial Law | Location: Adelaide SA 5000
· Adelaide CBD · Join a leading Adelaide commercial law firm
View details
National firms enable medicinal cannabis deal

National firms enable medicinal cannabis deal

Nicoletti

Piper Alderman and Steinpreis & Paginani advised in relation to the acquisition of a cannabis production and extraction company.

Firms: Piper Alderman (Atlas Pearls and Perfumes Limited’s fully owned subsidiary Essential Oils of Tasmania Pty Limited); Steinpreis & Paginani (Capital Mining Limited).

Deal: Capital Mining Limited has signed a non-binding term sheet to acquire 100 per cent of Cannabinoid Extracts Australia Pty Limited from Essential Oils of Tasmania Pty Limited, wholly owned by Atlas Pearls and Perfumes Limited.

Value: Confidential

Area: Pharmaceutical

Key players: Partners at Piper Alderman included Dr Teresa Nicoletti (pictured) and David Cornwell. The partner leading the Steinpreis & Paginani team was Peter Wall.

Deal significance: Cannabinoid Extracts Australia was set up by Essential Oils of Tasmania for the purpose of securing growing and processing licences for the manufacture of cannabinoid extracts.

As the medicinal cannabis industry is relatively new in Australia, the regulatory framework underpinning the cultivation of cannabis for therapeutic end use is still is a work in progress.

“The extraction of [cannabinoid] from industrial hemp (cannabis) has enormous therapeutic potential for those suffering from a wide range of conditions including epilepsy, multiple sclerosis and inflammatory disorders,” Dr Nicoletti said.

“Our involvement in assisting Cannabinoid Extracts Australia to establish a ground-breaking business that produces [cannabinoid] for supply in Australia and export globally is truly exciting.”

Promoted content
Recommended by Spike Native Network